Literature DB >> 6262272

Acyclovir in the management of herpes virus infections in immunosuppressed children.

A O'Meara, I B Hillary.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1981        PMID： 6262272     DOI： 10.1007/bf02938203

Source DB:  PubMed          Journal:  Ir J Med Sci        ISSN： 0021-1265            Impact factor:   1.568


× No keyword cloud information.
  6 in total

1.  Selectivity of action of an antiherpetic agent, 9-(2-hydroxyethoxymethyl) guanine.

Authors:  G B Elion; P A Furman; J A Fyfe; P de Miranda; L Beauchamp; H J Schaeffer
Journal:  Proc Natl Acad Sci U S A       Date:  1977-12       Impact factor: 11.205

2.  9-(2-hydroxyethoxymethyl) guanine activity against viruses of the herpes group.

Authors:  H J Schaeffer; L Beauchamp; P de Miranda; G B Elion; D J Bauer; P Collins
Journal:  Nature       Date:  1978-04-13       Impact factor: 49.962

3.  Acyclovir for treatment of mucocutaneous herpes infection in a child with leukaemia.

Authors:  A O'Meara; P F Deasy; I B Hillary; W D Bridgen
Journal:  Lancet       Date:  1979-12-01       Impact factor: 79.321

4.  Parenteral acyclovir therapy for herpesvirus infections in man.

Authors:  P J Selby; R L Powles; B Janeson; H E Kay; J G Watson; R Thornton; G Morgenstern; H M Clink; T J McElwain; H G Prentice; R Corringharn; M G Ross; A V Hoffbrand; D Brigden
Journal:  Lancet       Date:  1979-12-15       Impact factor: 79.321

5.  Randomised double-blind trial of acyclovir and idoxuridine in dendritic corneal ulceration.

Authors:  L M Collum; A Benedict-Smith; I B Hillary
Journal:  Br J Ophthalmol       Date:  1980-10       Impact factor: 4.638

6.  Efficacy of acycloguanosine (Wellcome 248U) against herpes-simplex corneal ulcers.

Authors:  B R Jones; D J Coster; P N Fison; G M Thompson; L M Cobo; M G Falcon
Journal:  Lancet       Date:  1979-02-03       Impact factor: 79.321
  6 in total
  3 in total

1.  Effect of combinations of acyclovir with vidarabine or its 5'-monophosphate on herpes simplex viruses in cell culture and in mice.

Authors:  R F Schinazi; J Peters; C C Williams; D Chance; A J Nahmias
Journal:  Antimicrob Agents Chemother       Date:  1982-09       Impact factor: 5.191

2.  Acyclovir therapy for chickenpox in children with hematological malignancies.

Authors:  J Bogusławska-Jaworska; E Kościelniak; B Rodziewicz
Journal:  Eur J Pediatr       Date:  1984-06       Impact factor: 3.183

Review 3.  Acyclovir. A review of its pharmacodynamic properties and therapeutic efficacy.

Authors:  D M Richards; A A Carmine; R N Brogden; R C Heel; T M Speight; G S Avery
Journal:  Drugs       Date:  1983-11       Impact factor: 9.546
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.